A DOCK1 INHIBITOR CAN INCREASE THE SENSITIVITY OF CYTARABINE ON DOCK1 OVEREXPRESSED ACUTE MYELOID LEUKEMIA CELL LINE

被引:0
|
作者
Yoshitomi, Masahiro [1 ]
Ikeda, Junji [1 ]
Tsujimoto, Shinichi [1 ,2 ]
Ito, Shuichi [1 ]
Hasegawa, Daisuke [2 ]
Iwamoto, Shotaro [2 ]
Hayashi, Yasuhide [3 ]
Adachi, Souichi [2 ]
Tomizawa, Daisuke [2 ]
Shiba, Norio [1 ,2 ]
机构
[1] Yokohama City Univ Med, Dept Pediat, Yokohama, Kanagawa, Japan
[2] JCCG, Tokyo, Japan
[3] Jobu Univ, Inst Physiol & Med, Gunma, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OS1-5
引用
收藏
页码:S12 / S12
页数:1
相关论文
共 50 条
  • [31] DOCK1 regulates the malignant biological behavior of endometrial cancer through c-Raf/ERK pathway
    Shangdan Xie
    Yanshan Jin
    Jiakun Wang
    Jingwei Li
    Mengjia Peng
    Xueqiong Zhu
    BMC Cancer, 24
  • [32] DOCK1 insufficiency disrupts trophoblast function and pregnancy outcomes via DUSP4-ERK pathway
    Xu, Yichi
    Liu, Xiaorui
    Zeng, Weihong
    Zhu, Yueyue
    Dong, Junpeng
    Wu, Fan
    Chen, Cailian
    Sharma, Surendra
    Lin, Yi
    LIFE SCIENCE ALLIANCE, 2024, 7 (02)
  • [33] DOCK1 inhibition suppresses cancer cell invasion and macropinocytosis induced by self-activating Rac1P29S mutation
    Tomino, Takahiro
    Tajiri, Hirotada
    Tatsuguchi, Takaaki
    Shirai, Takahiro
    Oisaki, Kounosuke
    Matsunaga, Shigeki
    Sanematsu, Fumiyuki
    Sakata, Daiji
    Yoshizumi, Tomoharu
    Maehara, Yoshihiko
    Kanai, Motomu
    Cote, Jean-Francois
    Fukui, Yoshinori
    Uruno, Takehito
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 497 (01) : 298 - 304
  • [34] DOCK1 regulates the malignant biological behavior of endometrial cancer through c-Raf/ERK pathway
    Xie, Shangdan
    Jin, Yanshan
    Wang, Jiakun
    Li, Jingwei
    Peng, Mengjia
    Zhu, Xueqiong
    BMC CANCER, 2024, 24 (01)
  • [35] Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial-mesenchymal transition
    Chen, Da-jin
    Chen, Wei
    Jiang, Hong
    Yang, Hao
    Wang, Yu-cheng
    Chen, Jiang-hua
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 2845 - 2853
  • [36] Genetic change investigation in DOCK1 gene in an Iranian family with sign and symptoms of temporomandibular joint disorder (TMD)
    Najafi, Shamsoulmolouk
    Hashemi-Gorji, Farzad
    Roudgari, Hassan
    Goudarzi, Mina
    Jafarzadegan, Amir Mohammad
    Sheykhbahaei, Nafiseh
    CLINICAL ORAL INVESTIGATIONS, 2024, 28 (08)
  • [37] Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer
    Feng, Junru
    Lu, Hui
    Ma, Wenhao
    Tian, Wenjing
    Lu, Zhuan
    Yang, Hongying
    Cai, Yongping
    Cai, Pengfei
    Sun, Yuchen
    Zhou, Zilong
    Feng, Jiaqian
    Deng, Jiazhong
    Shu, Ying
    Qu, Kun
    Jia, Weidong
    Gao, Ping
    Zhang, Huafeng
    PROTEIN & CELL, 2022, 13 (11) : 825 - 841
  • [38] Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer
    Junru Feng
    Hui Lu
    Wenhao Ma
    Wenjing Tian
    Zhuan Lu
    Hongying Yang
    Yongping Cai
    Pengfei Cai
    Yuchen Sun
    Zilong Zhou
    Jiaqian Feng
    Jiazhong Deng
    Ying Shu
    Kun Qu
    Weidong Jia
    Ping Gao
    Huafeng Zhang
    Protein & Cell, 2022, 13 (11) : 825 - 858
  • [39] MYLK*FLNB and DOCK1*LAMA2 gene-gene interactions associated with rheumatoid arthritis in the focal adhesion pathway
    Veyssiere, Maeva
    Ordonez, Maria del Pilar Rodriguez
    Chalabi, Smahane
    Michou, Laetitia
    Cornelis, Francois
    Boland, Anne
    Olaso, Robert
    Deleuze, Jean-Francois
    Petit-Teixeira, Elisabeth
    Chaudru, Valerie
    FRONTIERS IN GENETICS, 2024, 15
  • [40] Combinatorial Genetic Uncovers DOCK1/RAC2 As Specific Targets for the Treatment of NPM1;Cohesin Mutated AML
    Meyer, Alison E.
    Stelloh, Cary
    Pulakanti, Kirthi
    Burns, Robert
    Fisher, Joseph B.
    Heimbruch, Katelyn E.
    Tarima, Sergey
    Viny, Aaron D.
    Vassiliou, George S.
    Rao, Sridhar
    BLOOD, 2021, 138